No. of cases (%) | P | |||
---|---|---|---|---|
Total | AB | non-AB | ||
N = 108 | n = 60 | n = 48 | ||
Sex, male | 65 (60.2) | 31 (51.7) | 24 (50.0) | 0.863 |
Median age (IQR), years | 1.4 (0.1–7.9) | 1.5 (0.1–6.8) | 2.4 (0.4–11.3) | 0.164 |
Underlying disease | ||||
Malignancy | 23 (21.3) | 15 (25.0) | 8 (16.7) | 0.293 |
Congenital heart disease | 16 (14.8) | 11 (18.3) | 5 (10.4) | 0.250 |
Preterm, ELBWI | 17 (15.7) | 14 (23.3) | 3 (6.3) | 0.015 |
Solid organ transplant | 10 (9.3) | 5 (8.3) | 5 (10.4) | 0.710 |
Non-malignant chronic disease* | 40 (37.0) | 15 (25.0) | 25 (52.1) | 0.004 |
None | 2 (1.9) | 0 | 2 (4.2) | - |
Cultured specimen | ||||
Blood | 92 (85.2) | 52 (86.7) | 40 (83.3) | 0.628 |
Pleural fluid | 3 (2.8) | 3 (5.0) | 0 | - |
Ascites fluid | 13 (12.0) | 5 (8.3) | 8 (16.7) | 0.186 |
Location of admission | ||||
Ward | 37 (34.3) | 8 (13.3) | 30 (62.5) | < 0.001 |
ICU | 71 (65.7) | 53 (88.3) | 18 (37.5) | |
Duration of admission prior to infection, median days (IQR) | 14.0 (2.5–49.0) | 17.0 (6.0-43.5) | 9.0 (1.0–51.0) | 0.151 |
Mortality | ||||
7-day mortality | 26 (24.1) | 24 (40.0) | 2 (4.2) | < 0.001 |
30-day mortality | 32 (29.6) | 28 (46.7) | 4 (8.3) | < 0.001 |